Back
ANI Pharmaceuticals 10K Form
Sell
45
ANIP
ANI Pharmaceuticals
Last Price:
56.07
Seasonality Move:
6.92%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-10 | 10Q | ANIP/ANI Pharmaceuticals Quarterly |
2023-11-08 | 10Q | ANIP/ANI Pharmaceuticals Quarterly |
2023-08-09 | 10Q | ANIP/ANI Pharmaceuticals Quarterly |
2023-05-08 | 10Q | ANIP/ANI Pharmaceuticals Quarterly |
2022-11-09 | 10Q | ANIP/ANI Pharmaceuticals Quarterly |
2022-08-08 | 10Q | ANIP/ANI Pharmaceuticals Quarterly |
Receive ANIP News And Ratings
See the #1 stock for the next 7 days that we like better than ANIP
ANIP Financial Statistics
Sales & Book Value
Annual Sales: | $486.82M |
---|---|
Cash Flow: | $12.97M |
Price / Cash Flow: | 11.47 |
Annual Sales: | $21.64 |
Price / Book: | 2.58 |
Profitability
EPS (TTM): | 1.15000 |
---|---|
Net Income (TTM): | $27.02M |
Gross Margin: | $305.3M |
Return on Equity: | 5.86% |
Return on Assets: | 3.01% |
ANI Pharmaceuticals Earnings Forecast
Key ANI Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 16 years for ANIP is 62.71%.
- The Selling, General & Administrative Expenses for ANIP have been equal to 33.22% of Gross Profit Margin.
- The Research & Development expenses have been 7.04% of Revenue.
- The Interest Expense is 143.46% of Operating Income.
- The Net Earning history of ANIP is 3.86% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 12 years.
ANI Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | ANIP |
CUSIP: | 00182C |
Website: | anipharmaceuticals.com |
Debt
Debt-to-Equity Ratio: | 0.59 |
---|---|
Current Ratio: | 3.97 |
Quick Ratio: | 2.95 |
Price-to-Earnings
Trailing P/E Ratio: | 65.91 |
---|---|
Forward P/E Ratio: | 10.1 |
ANIP Technical Analysis vs Fundamental Analysis
Sell
45
ANI Pharmaceuticals (ANIP)
is a Sell
Is ANI Pharmaceuticals a Buy or a Sell?
-
ANI Pharmaceuticals stock is rated a Sell
The current ANI Pharmaceuticals [ANIP] share price is $56.02. The Score for ANIP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.